Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Is it important to you that the world have accurate information about drugs?
Please donate to support Erowid Center's vision!
Deprenyl
Basics
by Erowid
DESCRIPTION #
Selegiline, bettern known as Deprenyl, is an MAO-B Inhibitor in small quantities (under 25 mg) and also inhibits MAO-A in larger quantities. It was the first selective inhibitor of MAO-B. Selegiline is marketed as a Parkinson's disease cure. Other reported positive effects include cognitive enhancement, increased libido in men, and reports of life-span extension.

Effects are described as stimulating and a little similar to cocaine. Tolerance builds relatively quickly. The FDA approved a Selegine transdermal patch (Emsam) for use as an antidepressant in February, 2006.
Dose #
5 -15 mg / day
Price #
Price Summary Needed.
Law #
Law Summary Needed.
Chemistry Summary Needed.
Pharmacology #
Pharmacology Summary Needed.
Production #
Production Summary Needed.
History #
Deprenyl was first developed in the early 1960s by Dr. Joseph Knoll.
Terminology / Slang #
Brand Names:
ldepryl; Carbex; Eprenyl; EJumex; Movergan; Plurimen; Alzene; Selpak; Atapryl.
The Substance:
l-Deprenyl; Selegiline.
The Experience:
No common terms known.
EFFECTS #
Effects Summary Needed.
Onset #
Onset Summary Needed.
Duration #
Duration Summary Needed.
Visual Effects #
Visuals Summary Needed.
PROBLEMS #
Problems Summary Needed.
Contraindications #
  • Users of Emsam may be advised to avoid alcohol and foods containing tyramine.
  • Adverse effects are rare, but may include changes in blood pressure.
  • Pregnant women should consult their doctor before taking Deprenyl during pregnancy.

Addiction Potential #
Addiction Potential Summary Needed.
Long Term Health Problems #
Long Term Health Problems Summary Needed.
Risk of Death #
Risk of Death Summary Needed.
CAUTION & DISCLAIMER #
Erowid Basics pages are summaries of data gathered from site visitors, government documents, books, websites, and other resources. We do our best to keep this information correct and up-to-date, but the field is complex and constantly changing. Information should always be verified through multiple sources.